Jonathan Violin, Chief Executive Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 30,000 shares at $13.04 ($391K) on 2022-05-02, disclosed to the SEC on 2022-05-04.
Open-market sale of $391k VRDN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VRDN | SELL | 2022-04-05 | $1.1M | — | Filing → |
| VRDN | SELL | 2022-03-03 | $1.1M | — | Filing → |
| VRDN | SELL | 2022-02-03 | $1.1M | — | Filing → |